![FDA Approves Biosimilar Version of Successful Anti-angiogenic Cancer Drug, Bevacizumab|The Angiogenesis Foundation FDA Approves Biosimilar Version of Successful Anti-angiogenic Cancer Drug, Bevacizumab|The Angiogenesis Foundation](https://angio.org/wp-content/uploads/2007/09/FDAweb2.jpg)
FDA Approves Biosimilar Version of Successful Anti-angiogenic Cancer Drug, Bevacizumab|The Angiogenesis Foundation
![Low serum albumin is associated with mortality and arterial and venous ischemic events in acutely ill medical patients. Results of a retrospective observational study - ScienceDirect Low serum albumin is associated with mortality and arterial and venous ischemic events in acutely ill medical patients. Results of a retrospective observational study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0049384823000609-ga1.jpg)
Low serum albumin is associated with mortality and arterial and venous ischemic events in acutely ill medical patients. Results of a retrospective observational study - ScienceDirect
![PDF) Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy PDF) Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy](https://i1.rgstatic.net/publication/321326781_Paraneoplastic_Pemphigus_Insight_into_the_Autoimmune_Pathogenesis_Clinical_Features_and_Therapy/links/5a1f1a1e0f7e9b9d5e0277b8/largepreview.png)